Td Asset Management Inc Akero Therapeutics, Inc. Transaction History

Td Asset Management Inc

$114 Billion
Q3 2025

A detailed history of Td Asset Management Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 188,844 shares of AKRO stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

188,844

Previous 191,448 1.36%

Holding current value

$10.2 Million

Previous $10.2 Million 12.23%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$42.18 - $54.33 $109,836 - $141,475	-2,604 Reduced 1.36%	188,844 $8.97 Million
Q2 2025 Jul 28, 2025	SELL	$34.04 - $56.28 $592,296 - $979,272	-17,400 Reduced 8.33%	191,448 $10.2 Million
Q1 2025 May 07, 2025	BUY	$21.87 - $57.56 $857,172 - $2.26 Million	39,194 Added 23.1%	208,848 $8.45 Million
Q4 2024 Feb 11, 2025	BUY	$26.75 - $35.28 $1.24 Million - $1.63 Million	46,200 Added 37.42%	169,654 $4.72 Million
Q3 2024 Nov 01, 2024	SELL	$21.45 - $29.34 $667,910 - $913,588	-31,138 Reduced 20.14%	123,454 $3.54 Million

Q2 2024 Aug 02, 2024	BUY	$18.31 - $24.62 $541,976 - $728,752	29,600 Added 23.68%	154,592 $3.63 Million
Q1 2024 May 08, 2024	BUY	$17.76 - $31.18 $546,830 - $960,032	30,790 Added 32.69%	124,992 $3.16 Million
Q4 2023 Feb 12, 2024	SELL	$11.38 - $50.33 $362,908 - $1.61 Million	-31,890 Reduced 25.29%	94,202 $2.2 Million
Q3 2023 Oct 27, 2023	BUY	$41.19 - $52.25 $2.61 Million - $3.31 Million	63,346 Added 100.96%	126,092 $6.38 Million
Q2 2023 Aug 09, 2023	BUY	$36.89 - $56.88 $174,268 - $268,701	4,724 Added 8.14%	62,746 $2.93 Million
Q1 2023 May 10, 2023	BUY	$37.27 - $50.24 $208,712 - $281,344	5,600 Added 10.68%	58,022 $2.22 Million
Q4 2022 Feb 06, 2023	BUY	$33.44 - $54.8 $1.11 Million - $1.82 Million	33,300 Added 174.14%	52,422 $2.87 Million
Q3 2022 Nov 07, 2022	BUY	$10.15 - $34.05 $194,088 - $651,104	19,122 New	19,122 $570,000
Q1 2022 May 10, 2022	SELL	$12.97 - $22.26 $325,572 - $558,770	-25,102 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.04 - $34.19 $132,147 - $187,942	5,497 Added 28.04%	25,102 $728,000
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $100,480 - $119,560	4,000 Added 25.63%	19,605 $506,000
Q3 2020 Nov 10, 2020	BUY	$30.79 - $39.92 $211,927 - $274,769	6,883 Added 78.92%	15,605 $480,000
Q2 2020 Aug 13, 2020	BUY	$19.25 - $26.76 $167,898 - $233,400	8,722 New	8,722 $217,000
Q1 2020 May 15, 2020	SELL	$12.8 - $27.05 $132,121 - $279,210	-10,322 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$16.89 - $29.88 $174,338 - $308,421	10,322 New	10,322 $235,000

Others Institutions Holding AKRO

# of Institutions

299

Shares Held

91.4M

Call Options Held

1.04M

Put Options Held

372K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Akero Therapeutics, Inc. Transaction History